Comments from curator
No phenotype data: this study was rejected because it is not a Drosophila study.This
article is a clinical review on human patients. It describes the surge of catecholamines after traumatic brain injury (TBI), its links with cardiac, pulmonary, coagulation and inflammatory complications and with outcome, and the clinical trials, observational studies and meta-analyses that associate beta-blocker treatment with lower mortality and better functional outcome after TBI. It reports no experiment of its own, uses no DGRP line and does not mention
Drosophila.
The DGRP study on the same subject is
Scharenbrock et al., 2021, microPublication Biology (
PMC version). It measured early mortality (MI
24) and intestinal permeability (SI
24) after traumatic brain injury in 18 DGRP lines fed the beta-blockers labetalol or metoprolol. Its per-line values are only shown in a figure. This record was probably meant for that paper.